Phase I Study of 17-Allylamino-17 Demethoxygeldanamycin, Gemcitabine and/or Cisplatin in Patients With Refractory Solid Tumors
Investigational New Drugs - Netherlands
doi 10.1007/s10637-009-9381-y
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2010
Authors
Publisher
Springer Science and Business Media LLC